UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 166

Sortiert nach

Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy

Journal of internal medicine, 2012-05, Vol.271 (5), p.499-509

2012

Volltextzugriff (PDF)

Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production

Apoptosis (London), 2005-08, Vol.10 (4), p.895-907

2005

Volltextzugriff (PDF)

Increasing ornithine decarboxylase activity is another way of prolactin preventing methotrexate-induced apoptosis: crosstalk between ODC and BCL-2

Apoptosis (London), 2006-03, Vol.11 (3), p.389-399

2006

Volltextzugriff (PDF)

Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines

Anticancer research, 2000-09, Vol.20 (5A), p.3221

2000

Volltextzugriff (PDF)

Comparative investigation on the mutagenicities of organophosphate, phthalimide, pyrethroid and carbamate insecticides by the Ames and lactam tests

Mutagenesis, 1998-03, Vol.13 (2), p.157-166

1998

Volltextzugriff (PDF)

Suppression of N-methyl- N′-nitro- N-nitrosoguanidine- and S-nitrosoglutathione-induced apoptosis by Bcl-2 through inhibiting glutathione- S-transferase π in NIH3T3 cells

Toxicology letters, 1999-11, Vol.110 (3), p.191-202

1999

Volltextzugriff (PDF)

Inhibition of Eleven Mutagens by Various Tea Extracts, (−)Epigallocatechin-3-gallate, Gallic Acid and Caffeine

Food and chemical toxicology, 1999-06, Vol.37 (6), p.569-579

1999

Volltextzugriff (PDF)

Arsenic trioxide as a novel anticancer agent against human transitional carcinoma—characterizing its apoptotic pathway

Anti-cancer drugs, 2002-03, Vol.13 (3), p.293-300

2002

Volltextzugriff (PDF)

Differential Expression of Molecular Markers in Arsenic- and Non-arsenic-related Urothelial Cancer

Anticancer research, 2006-01, Vol.26 (1A), p.375-378

2006

Volltextzugriff (PDF)

CROSS-RESISTANCE AND COMBINED CYTOTOXIC EFFECTS OF PACLITAXEL AND CISPLATIN IN BLADDER CANCER CELLS

The Journal of urology, 2001-06, Vol.165 (6), p.2082-2085

2001

Volltextzugriff (PDF)

High Expression of Acetyl-Tubulin as a Chemoresistant Biomarker in Human Docetaxel-Resistance Prostate Cancer Cells

Annals of oncology, 2012-10, Vol.23, p.xi133

2012

Volltextzugriff (PDF)

Resistance to paclitaxel is proportional to cellular total antioxidant capacity

Cancer research (Chicago, Ill.), 2005-09, Vol.65 (18), p.8455-8460

2005

Volltextzugriff (PDF)

Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate Cancers

ISRN oncology, 2011-01, Vol.2011, p.405656-7

2011

Volltextzugriff (PDF)

A new mutagenicity assay method for frameshift mutagens based on deleting or inserting a guanosine nucleotide in the β-lactamase gene

Mutagenesis, 1995-09, Vol.10 (5), p.433-438

1995

Volltextzugriff (PDF)

Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma

Journal of biomedical science, 2008-03, Vol.15 (2), p.261-269

2008

Volltextzugriff (PDF)

Downregulation of ABCD1 in human renal cell carcinoma

The International journal of biological markers, 2009-07, Vol.24 (3), p.171-178

2009

Volltextzugriff (PDF)

Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells

The Prostate, 2004-07, Vol.60 (2), p.120-129

2004

Volltextzugriff (PDF)

The PKC delta inhibitor, rottlerin, induces apoptosis of haematopoietic cell lines through mitochondrial membrane depolarization and caspases' cascade

Life sciences (1973), 2005-06, Vol.77 (6), p.707-719

2005

Volltextzugriff (PDF)

Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells

Biochemical pharmacology, 2006-03, Vol.71 (6), p.751-760

2006

Volltextzugriff (PDF)

CROSS-RESISTANCE AND COMBINED CYTOTOXIC EFFECTS OF PACLITAXEL AND CISPLATIN IN BLADDER CANCER CELLS

The Journal of urology, 2001-06, p.2082-2085

2001

Volltextzugriff (PDF)

Induction of apoptosis in human leukemia K562 cells by cardiotoxin III

Life sciences (1973), 2005-04, Vol.76 (21), p.2513-2522

2005

Volltextzugriff (PDF)

Suppression of transcription factor NF-kappaB activity by Bcl-2 protein in NIH3T3 cells: implication of a novel NF-kappaB p50-Bcl-2 complex for the anti-apoptotic function of Bcl-2

European journal of cell biology, 2000-02, Vol.79 (2), p.121-129

2000

Volltextzugriff (PDF)

Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide

Anti-cancer drugs, 2004-09, Vol.15 (8), p.779-785

2004

Volltextzugriff (PDF)

Inhibition of eleven mutagens by various tea extracts, (-)epigaliocatechin-3-gallate, gallic acid and caffeine

Food and chemical toxicology, 1999, Vol.37 (6), p.569-579

1999

Volltextzugriff (PDF)

Suppression of transcription factor NF-κB activity by Bcl-2 protein in NIH3T3 cells: implication of a novel NF-κB p50-Bcl-2 complex for the anti-apoptotic function of Bcl-2

European journal of cell biology, 2000-02, Vol.79 (2), p.121-129

2000

Volltextzugriff (PDF)

1 – 25 von 166

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Life Sciences & Biomedicine
(89)
Humans
(80)
Biological And Medical Sciences
(49)
Medical Sciences
(39)
Male
(34)
Female
(27)
Technology
(22)
Middle Aged
(18)
Animals
(17)
Adult
(16)
Fundamental And Applied Biological Sciences. Psychology
(16)
General & Internal Medicine
(16)
Infectious Diseases
(15)
Pharmacology. Drug Treatments
(14)
Computer Science
(13)
Medicine, General & Internal
(13)
Apoptosis
(12)
Engineering
(12)
Taiwan - Epidemiology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy

Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production

Increasing ornithine decarboxylase activity is another way of prolactin preventing methotrexate-induced apoptosis: crosstalk between ODC and BCL-2

Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines

Comparative investigation on the mutagenicities of organophosphate, phthalimide, pyrethroid and carbamate insecticides by the Ames and lactam tests

Suppression of N-methyl- N′-nitro- N-nitrosoguanidine- and S-nitrosoglutathione-induced apoptosis by Bcl-2 through inhibiting glutathione- S-transferase π in NIH3T3 cells

Inhibition of Eleven Mutagens by Various Tea Extracts, (−)Epigallocatechin-3-gallate, Gallic Acid and Caffeine

Arsenic trioxide as a novel anticancer agent against human transitional carcinoma—characterizing its apoptotic pathway

Differential Expression of Molecular Markers in Arsenic- and Non-arsenic-related Urothelial Cancer

CROSS-RESISTANCE AND COMBINED CYTOTOXIC EFFECTS OF PACLITAXEL AND CISPLATIN IN BLADDER CANCER CELLS

High Expression of Acetyl-Tubulin as a Chemoresistant Biomarker in Human Docetaxel-Resistance Prostate Cancer Cells

Resistance to paclitaxel is proportional to cellular total antioxidant capacity

Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate Cancers

A new mutagenicity assay method for frameshift mutagens based on deleting or inserting a guanosine nucleotide in the β-lactamase gene

Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma

Downregulation of ABCD1 in human renal cell carcinoma

Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells

The PKC delta inhibitor, rottlerin, induces apoptosis of haematopoietic cell lines through mitochondrial membrane depolarization and caspases' cascade

Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells

CROSS-RESISTANCE AND COMBINED CYTOTOXIC EFFECTS OF PACLITAXEL AND CISPLATIN IN BLADDER CANCER CELLS

Induction of apoptosis in human leukemia K562 cells by cardiotoxin III

Suppression of transcription factor NF-kappaB activity by Bcl-2 protein in NIH3T3 cells: implication of a novel NF-kappaB p50-Bcl-2 complex for the anti-apoptotic function of Bcl-2

Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide

Inhibition of eleven mutagens by various tea extracts, (-)epigaliocatechin-3-gallate, gallic acid and caffeine

Suppression of transcription factor NF-κB activity by Bcl-2 protein in NIH3T3 cells: implication of a novel NF-κB p50-Bcl-2 complex for the anti-apoptotic function of Bcl-2

Suchergebnisse filtern